Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dennis Ladnier"'
Autor:
Kawther Abdilleh, Omar Khalid, Dennis Ladnier, Wenshuai Wan, Sara Seepo, Garrett Rupp, Valentin Corelj, Zelia F. Worman, Bruce Press, Jack DiGiovanna, Satty Chandrashekhar, Eric Collisson, Karen Cui, Anirban Maitra, Paul A. Rejto, Kevin White, Lynn Matrisian, Sudheer Doss
Publikováno v:
Cancer Research. 82:A008-A008
The Pancreatic Cancer Action Network (PanCAN) is leading large-scale research initiatives that will help transform the way pancreatic cancer is detected and treated including the Know Your Tumor precision medicine service, the Precision Promise adapt
Autor:
Terry A. McNearney, Biai D.E. Digbeu, Dennis Ladnier, Kawther Abdilleh, Sudheer Doss, Lynn M. Matrisian, Jacques G. Baillargeon
Publikováno v:
Cancer Research. 82:A020-A020
Objective: This study assessed the pancreatic cancer (PC) patient-reported burdens of PC pain from 2016-2020 in an online patient-reported outcomes (PRO) survey supported by the Pancreatic Cancer Action Network (PanCAN). Assessments of PC symptoms, P
Autor:
James M. Davison, Dennis Ladnier, Lynn M. Matrisian, Kirk Beebe, Eric A. Collisson, Greg Mayhew, Joel R. Eisner
Publikováno v:
Cancer Research. 81:PO-002
Introduction: The Know Your Tumor (KYT) pancreas cancer program enables molecular analysis of both tumor DNA and mRNA to characterize tumor phenotypes and guide potential treatment options. The primary objective of the current study was to develop an
Autor:
Sudheer Doss, Andrew Eugene Hendifar, Colin D. Weekes, Omar Khalid, Ryan D. Nipp, Arjun Gupta, Crystal S. Denlinger, Andrew L. Coveler, Dennis Ladnier, Lynn M. Matrisian, Cassadie Moravek, Eric Roeland, Anica Lamkin
Publikováno v:
Web of Science
154 Background: By allowing patients (pts) to self-report key issues related to their quality of life and symptoms, PROs have important clinical and research implications. The PanCAN Registry, which began collecting data in July 2015, is a pancreatic